<DOC>
	<DOCNO>NCT00152412</DOCNO>
	<brief_summary>4 week open study evaluate safety levocetirizine young child ( 2 - 6 year ) suffer allergic rhinitis . As secondary objective , study assess efficacy treatment mean T4SS ( Total 4 symptom score allergic rhinitis ) 4 individual rhinitis symptom score</brief_summary>
	<brief_title>Open Study Evaluate Safety Levocetirizine Young Children ( 2 - 6 Years ) Suffering From Allergic Rhinitis</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Levocetirizine</mesh_term>
	<mesh_term>Cetirizine</mesh_term>
	<criteria>At Visit 1 : Male female outpatient age 2 6 year old . Subjects suffer allergic rhinitis ( perennial and/or seasonal ) symptomatic attest Daily Record Card ( DRC ) . At Visit 2 : Respected washout period forbidden medication . â€¢ Presence asthma require treatment inhaled corticosteroid . Atopic dermatitis urticaria require antihistamine treatment administration oral topical corticosteroid , disease require administration oral topical corticosteroid , immunomodulatory drug , antiinflammatory , cytotoxic drug . Use course study , specific washout period , follow medication : intranasal systemic corticosteroid ( within 7 day ) , ketotifen ( within 7 day ) , nedocromil cromoglicate ( within 7 day ) , loratadine desloratadine ( within 7 day ) , antihistamine ( within 3 day ) decongestant ( per o , nasal spray , drop within 3 day ) , concomitant medication , opinion Investigator , interfere study . Initiation change dose immunotherapy regimen course study .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Allergic Rhinitis , safety , levocetirizine , child</keyword>
	<keyword>Xyzal</keyword>
</DOC>